From molecular cardiology to emergency medical practice: The role of inflammatory markers

American Journal of Emergency Medicine

Volumn 30, Issue 7, 2012, Pages 1210-1211

  Vazquez, Joyce ^a,b   Varon, Joseph ^c,d,e  

^a Dorrington Medical Associates PA   (United States)

^b UNIVERSIDAD ANÁHUAC   (Mexico)

^c University General Hospital   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

CARDIOLOGY; EMERGENCY MEDICINE; ENZYME BLOOD LEVEL; EXTRACELLULAR MATRIX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HUMAN; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESUSCITATION; REVIEW;

EID: 84865468641     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2011.07.020     Document Type: Editorial

References (11)

1. M.A.M. Ali, W.J. Cho, B. Hudson, Z. Kassiri, H. Granzier, and R. Schulz Titin is a target of matrix metalloproteinase-2: clinical perspective Circulation 122 20 2010 2039 2047
2. E.E.J.M. Creemers, J.P.M. Cleutjens, J.F.M. Smits, and M.J.A.P. Daemen Matrix metalloproteinase inhibition after myocardial infarction Circ Res 89 3 2001 201 210
3. A.B. Osherov, L. Gotha, A.N. Cheema, B. Qiang, and B.H. Strauss Proteins mediating collagen biosynthesis and accumulation in arterial repair: novel targets for anti-restenosis therapy Cardiovas Res 91 1 2011 16 26
4. J. Hu, P.E. Van den Steen, Q.X.A. Sang, and G. Opdenakker Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases Nat Rev Drug Discov 6 6 2007 480 498
5. R. Visse, and H. Nagase Matrix metalloproteinases and tissue inhibitors of metalloproteinases Cir Res 92 8 2003 827 839
6. A. Goetzenich, N. Hatam, A. Zernecke, C. Weber, T. Czarnotta, and R.d. Autschbach Alteration of matrix metalloproteinases in selective left ventricular adriamycin-induced cardiomyopathy in the pig J. Heart Lung Transplant 28 10 2009 1087 1093
7. J. Zhong, H. Liu, Q. Zeng, X. Meng, D. Liu, and G. Su An imbalance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 after CPR of prolonged ventricular fibrillation Am J Emerg Med 2011
8. F.G. Spinale Matrix metalloproteinases: regulation and dysregulation in the failing heart Circ Res 90 5 2002 520 530
9. T.C. McQuinn, R.L. Deardorff, R. Mukherjee, A.G.B. Taylor, E.M. Graham, and A.M. Atz Circulating matrix metalloproteinase levels after ventricular septal defect repair in infants J Thorac Cardiovasc Surg 140 6 2010 1257 1265
10. L.E. Rohde, A. Ducharme, L.H. Arroyo, M. Aikawa, G.H. Sukhova, and A. Lopez-Anaya Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice Circulation 99 23 1999 3063 3070
11. S. Blankenberg, H.J. Rupprecht, O. Poirier, C. Bickel, M. Smieja, and G. Hafner Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease Circulation 107 12 2003 1579 1585